Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology

Speaker: Zihan Qiu, - Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

03:00pm - 04:00pm ET

Surgical Margins and the Risk of Local Regional Recurrence (LRR) Following Mastectomy

Speaker: Jordan Tralins, BS - Harvard Medical, Boston

03:00pm - 04:00pm ET

A Multi-Institutional Pooled Analysis of Women with pT1-2N1 Breast Cancer after Mastectomy and Sentinel Lymph Node Biopsy Only and Adjuvant Post-Mastectomy Radiation

Speaker: Sarah Sittenfeld, MD - University of Cincinnati, Cincinnati

03:00pm - 04:00pm ET

Voxel-Based Analysis Unveils the Optimal Esophageal Contouring and Dose Constraint to Predict Radiation Esophagitis in Postmastectomy Regional Nodal Radiotherapy

Speaker: Dan-Qiong Wang, MD - National Cancer Center/ National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Acade, ???

03:00pm - 04:00pm ET

Impact of Endocrine Therapy Adherence on Locoregional Recurrence following Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer

Speaker: Elizabeth Obi, MD - Cleveland Clinic Foundation, Cleveland

03:00pm - 04:00pm ET

Deep Learning-Based Cross-Center Ordinal Grading of Radiation Dermatitis In Breast Cancer Radiotherapy

Speaker: Zihan Shi, - Xijing Hospital, Xian 710032

03:00pm - 04:00pm ET

Prospective Evaluation of Quality of Life and Clinicopathological Predictors in Locally Advanced Cervical Cancer Treated with Definitive Chemoradiotherapy and CT-Guided Brachytherapy

Speaker: Keerthiga Karthikeyan, MBBS, DNB - Mahatma Gandhi Cancer Hospital & Research Institute, Visakhapatnam, visakhapatnam

03:00pm - 04:00pm ET

Genomically-Guided Regional Nodal Irradiation in Luminal Breast Cancer Using MammaPrint

Speaker: Anna Slingerland, MD, BS - Mount Sinai Health System, New York

03:00pm - 04:00pm ET

Dosimetric Benefits of Online Adaptive Accelerated Partial Breast Irradiation In Early-Stage Breast Cancer

Speaker: Odette Iskandar, MD, MBBS - Temple University Hospital/Fox Chase Cancer Center, Philadelphia

03:00pm - 04:00pm ET

Evaluating the Effects of Regional Nodal Radiation in Node-Positive Triple-Negative Breast Cancer: Identifying the Beneficiaries

Speaker: Swarupa Mitra, MD, MBA, MBBS - Rajiv Gandhi Cancer Institute & Research Centre, Delhi

03:00pm - 04:00pm ET

Longitudinal Dynamics and Recovery of Lymphocytes In Patients with Breast Cancer Receiving Radiotherapy without Chemotherapy after Breast-Conserving Surgery: A Second Analysis of a Phase III Randomized Trial

Speaker: Yuchun Song, MD - Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

03:00pm - 04:00pm ET

Navigating Nodes: Outcomes of Proton Therapy for Regional Nodal Irradiation in Breast Cancer

Speaker: Erica Braschi Jordan, MD - University of Florida, Gainesville

03:00pm - 04:00pm ET

Outcomes after Mutimodality Therapy for Clinically Internal Mammary Node Positive Breast Cancer: A Retrospective Cohort Study

Speaker: Xuwen Shen, MD - cancer hospital of Chinese academy of Sciences, Beijing

03:00pm - 04:00pm ET

Accelerated Partial Breast Irradiation in Early-Stage Breast Cancer Patients with High Oncotype DX Scores: An Institutional Retrospective Review

Speaker: Kaidi Wang, MD - Ohio State University Hospital, Columbus

03:00pm - 04:00pm ET

Safety and Efficacy of Concurrent Tyrosine Kinase Inhibitors (TKIs) and Cranial Radiotherapy for HER2-Positive Breast Cancer Brain Metastases: A Retrospective Real-World Study

Speaker: Chaonan Zhang, MD - National Cancer Center/National Clinical Research Center for Cance, Beijing

03:00pm - 04:00pm ET

Long-Term Outcomes of Risk-Adapted Targeted Intraoperative Radiotherapy vs. External Beam Radiotherapy in Early Breast Cancer: Post-Hoc As-Treated Analysis of the German Cohort of the TARGIT-A Trial

Speaker: Gustavo Sarria, MD - University Hospital Bonn, Bonn

03:00pm - 04:00pm ET

Clinical Outcomes of De Novo Oligometastatic Breast Cancer Patients Treated with Curative Intent

Speaker: Celina Chiodo, MD, MS - Moffitt Cancer Center, Tampa

03:00pm - 04:00pm ET

Identifying Risk Factors for an AI Model to Predict Skin Toxicity in Breast Radiation

Speaker: Raleigh Anderson, MD - Thomas Jefferson University, Philadelphia

03:00pm - 04:00pm ET

Reconstruction Outcomes of Post-Mastectomy Radiotherapy with Proton Therapy: A Multi-Institutional Analysis

Speaker: Seraphina Choi, MD - University of Southern California (USC) /LA General Medical Center, Los Angeles

03:00pm - 04:00pm ET

Re-Evaluating the Role of Post-Mastectomy Radiation Therapy for Node-Negative Breast Cancer in the Modern Therapy Era: A Matched Cohort Analysis of SUPREMO Trial

Speaker: Yajuan Chu, MD - Fudan University Shanghai Cancer Center, Shanghai

03:00pm - 04:00pm ET

The Impact of Clinical and Dosimetric Factors on the Incidence of Radiation Induced Lung Injury (RILI) in Breast Cancer Patients Treated with Volumetric Arc Therapy (VMAT)

Speaker: Rimoun Boutrus, MD, PhD - Bahrain Oncology Center, Muharraq

03:00pm - 04:00pm ET

Outcomes of Routine Breast MRI Use in the Surgical Evaluation of Breast Cancer

Speaker: Rami Shaker, MD, MHI - University of Florida College of Medicine, Gainesville

03:00pm - 04:00pm ET

Recurrence Patterns in Triple-Negative Breast Cancer Following Breast-Conserving Surgery with Radiotherapy Compared to Mastectomy

Speaker: Swarupa Mitra, MD, MBA, MBBS - Rajiv Gandhi Cancer Institute & Research Centre, Delhi

03:00pm - 04:00pm ET

Predictors of Patient Reported Outcomes of Breast Cosmesis Following Breast Radiation

Speaker: Karthik Meiyappan, MD - Winship Cancer Institute of Emory University, Atlanta

03:00pm - 04:00pm ET

Target Coverage Robustness with 2 mm PTV for Adaptive Accelerated Partial Breast Irradiation

Speaker: John Hoyle, MD, MS - University of Alabama Birmingham School of Medicine, Birmingham

03:00pm - 04:00pm ET

A Prospective Pilot Study of Acute Symptoms and Toxicities Among Patients Undergoing Curative or Palliative-Intent Non-Ablative Short Course Pelvic Radiotherapy for De Novo or Locally Recurrent Rectal or Rectosigmoid Cancer (SHORT-TOX Study)

Speaker: Michael Sun, MD - University of Ottawa, Ottawa

03:00pm - 04:00pm ET

ctDNA Evaluation on a Phase I Trial of Pre-Operative Ablative Radiation for Early Stage Hormone Positive Breast Cancer

Speaker: Asal Rahimi, MD, MS - University of Texas Southwestern Medical Center at Dallas, Dallas

03:00pm - 04:00pm ET

Analysis of Breast Cancer Patients' Suggestions for Interventions to Alleviate Financial Toxicity

Speaker: Kelvin Ziegler, DO - Maimonides Cancer Center, Brooklyn

03:00pm - 04:00pm ET

Risk Factors for High-Grade Dermatitis Following Breast/Chest Wall and Regional Nodal Irradiation with Proton Beam Radiotherapy: Results of a Multi-Institutional Prospective Registry Trial

Speaker: Dulcce Valenzuela, MS, BS - Inova Schar Cancer Institute, Fairfax

03:00pm - 04:00pm ET

Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations after Neo-Adjuvant Systemic Therapy and Surgery: A Feasibility Study

Speaker: Fereshteh Talebi, MD - Harbor-UCLA Medical Center, Los Angeles

03:00pm - 04:00pm ET

Cardiopulmonary Dosimetric Analysis of Radiotherapy Techniques Using an Ultra-Hypofractionated Regimen for Left-Sided Breast Cancer: A Latin American Single-Center Experience

Speaker: Guillermo Pacheco-Gutierrez, MD - Instituto Nacional de Cancerologia, Mexico City

03:00pm - 04:00pm ET

Impact of Daily Anatomical Variations on Delivered Dose in Hypofractionated Whole Breast Proton Beam Therapy

Speaker: Olivia Moncrief, BS - LSU Health Sciences Center Shreveport, Shreveport

03:00pm - 04:00pm ET

Retrospective Cohort Study Evaluating Outcomes in Patients with and without Implants prior to Diagnosis of Early-Stage Breast Cancer Receiving APBI in 25 Gy in 5 Fractions vs. 21.9 Gy in 3 Fractions

Speaker: Hiral Ahir, BS - A T STILL University, Mesa

03:00pm - 04:00pm ET

Comparative Evaluation of 3D-CRT, VMAT, and PBS-PT for Bilateral Breast/Chest Wall and Regional Nodal Irradiation

Speaker: Gideon Haber, MD, MS - Memorial Sloan Kettering Cancer Center, New York

03:00pm - 04:00pm ET

Individualizing Post-Mastectomy Radiotherapy Benefit in Breast Cancer Using a Causal Survival Forest: Development and External Validation

Speaker: Jingnan Wang, MD - Cancer Hospital Chinese Academy of Medical Sciences, Beijing

03:00pm - 04:00pm ET

Unmet Needs and Treatment Priorities in Oral Mucositis Management during Head and Neck Radiotherapy

Speaker: Michelle Ann Eala, MD, MBA - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles

03:00pm - 04:00pm ET

A Simplified Predictive Model for Residual Axillary Disease on Completion Dissection After Neoadjuvant Chemotherapy with Positive Sentinel Node Biopsy Using Clinical Nodal Stage and Nodal Residual Cancer Burden

Speaker: Tomas Dvorak, MD - Orlando Health Cancer Institute, Orlando

03:00pm - 04:00pm ET

Local Control in Metastatic Breast Cancer: Outcomes of Hypofractionated Radiotherapy and SBRT for Locoregional Oligoprogression During Systemic Therapy

Speaker: Esengul Kocak, MD - MD Anderson Cancer Center, Houston

03:00pm - 04:00pm ET

Machine Learning-Based Multimodal Prognostic Model and Exploration of Prognostic Markers in Triple-Negative Breast Cancer

Speaker: Mengli Zhou, MD - ShenZhen Cancer Hospital, ShenZhen

03:00pm - 04:00pm ET

Dermoscopic Evaluation of Radiation-Induced Dermatitis In Breast Cancer Patients Receiving Adjuvant Radiotherapy

Speaker: Saikat Das, MD, PhD - All India Institute of Medical Sciences Bhopal, Bhopal

03:00pm - 04:00pm ET

Characterizing Patterns of Progression on Sacituzumab Govitecan Among Patients with Triple Negative Metastatic Breast Cancer

Speaker: Emily Hollis, MD - UNC School of Medicine, Chapel Hill

03:00pm - 04:00pm ET

Heart and Cardiac Substructure Sparing Intensity-Modulated Proton Therapy for Non-Metastatic Breast Cancer: Real-World Prospective Registry Outcomes from India

Speaker: Sapna Nangia, MD, MBBS - Apollo Proton Cancer Centre, Chennai

03:00pm - 04:00pm ET

Disease-Free Interval as an Independent Predictor of Survival Following Ipsilateral Recurrence of Early-Stage Breast Cancer

Speaker: David Miller, MD, MS - Memorial Sloan Kettering Cancer Center, New York

03:00pm - 04:00pm ET

Outcomes and Toxicity of Concurrent CDK46 Inhibitor and Adjuvant Radiation Therapy in Early Breast Cancer

Speaker: Yao Song, MD, PhD - Department of Radiation Oncology, Shanghai Tenth People’s Hospital of Tongji University, shanghai

03:00pm - 04:00pm ET

Radiotherapy Patterns of Care and Toxicities after Breast Conserving Surgery with or without Immediate Reconstruction for Early-Stage Breast Cancer

Speaker: Shrey Ramesh, BS - Medical College of Wisconsin, Milwaukee

03:00pm - 04:00pm ET

Comparing Standard and Magnetic Resonance-Guided Linear Accelerators for Accelerated Partial Breast Irradiation: Early Toxicities and Dosimetric Outcomes

Speaker: Shing Fung Lee, MBBS - National University Hospital, Singapore

03:00pm - 04:00pm ET

Prognostic Determinants of Survival in Oligometastatic Breast Cancer (OMBC): The Role of Timing and Metastatic Burden

Speaker: Shagun Misra, MD, MBBS - Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow

03:00pm - 04:00pm ET

Simultaneous Integrated Proton Boost vs. Sequential Proton Boost in Node-Positive Breast Cancer: A Dosimetric Analysis of Normal Tissue Exposure and Biologically Effective Dose

Speaker: Natalia Martynova, MD - Dr. Berezin Medical Institute, Saint-Petersburg

03:00pm - 04:00pm ET

Long-Term Recurrence Outcomes After HDR Brachytherapy Accelerated Partial Breast Irradiation Stratified by Genomic Risk in Early-Stage Breast Cancer

Speaker: John Wilson V, BS - University of South Florida, Tampa

03:00pm - 04:00pm ET

Contralateral Breast Dose among Young Patients Receiving Breast Radiotherapy: Incidence and Implications

Speaker: Allison Matous, MD - Dartmouth-Hitchcock Medical Center, Lebanon

03:00pm - 04:00pm ET

Bridging the Gap In Sexual Health Communication during Prostate Cancer Consultation

Speaker: Ziyi Huang, MD - City of Hope, Upland

03:00pm - 04:00pm ET

Longitudinal Multi-omic Immune Profiling and Persistent Systemic Dysregulation and Baseline Predictors of Recurrence after Breast Cancer Radiotherapy

Speaker: Zeliang Ma, MD - Mayo Clinic Rochester, Rochester

03:00pm - 04:00pm ET

Dose-LET Interactions Predict Capsular Contracture after Proton Postmastectomy Radiation Therapy

Speaker: Zeliang Ma, MD - Mayo Clinic Rochester, Rochester

03:00pm - 04:00pm ET

Dual HER2 Blockade Is Associated with Increased Cardiovascular Events In Patients with Breast Cancer Receiving Multimodality Therapy

Speaker: Maria Oorloff, BS - Cedars Sinai Medical Center, Los Angeles

03:00pm - 04:00pm ET

National Trends in Radiation Fractionation for Breast Cancer in Relation to the COVID-19 Pandemic

Speaker: Manish Suryapalam, MD, BS - UCLA David Geffen School of Medicine/UCLA Medical Center, Los Angeles

03:00pm - 04:00pm ET

Predictors of Implant Failure in Patients Receiving Post-Mastectomy Radiation Therapy

Speaker: Yastira Ramdas, MD - William Beaumont Hospital, Royal Oak

03:00pm - 04:00pm ET

Practical Approach to Reducing Skin Toxicity in Breast IMPT

Speaker: Jared Capuano, BS - Emory University, Bethesda

03:00pm - 04:00pm ET

Spatial Analysis of Local Recurrence Patterns after Mastectomy and Reconstruction for Breast Cancer

Speaker: WaiLok Lui, MD - Fudan University Shanghai Cancer Center, Shanghai

03:00pm - 04:00pm ET

A Phase II Trial of Stereotactic Body Radiation Therapy and Fluoroestradiol Positrom Emission Tomography in Patients with Oligoprogressive Estrogen Receptor-Positive Metastatic Breast Cancer

Speaker: Jose Bazan, MD, MS - City of Hope National Medical Center, Duarte

03:00pm - 04:00pm ET

Real-Time Monitoring of Patient Centered Outcomes in Patients Undergoing Pelvic Radiation - A Randomized Controlled Trial

Speaker: May Elbanna, MD, PhD - Mayo Clinic Rochester, Rochester

03:00pm - 04:00pm ET

Pretreatment Mammography Deep Learning to Predict Luminal and TNBC Phenotypes in Early Breast Cancer: A Timely Decision-Support Tool When CNB-IHC is Discordant or Unavailable for Retesting

Speaker: Menghan Zhang, - Fudan University Shanghai Cancer Center, Shanghai

03:00pm - 04:00pm ET

Patient-Reported Outcomes during Radiotherapy for Mycosis Fungoides and Other Cutaneous Lymphomas

Speaker: Kaitlyn Lapen, MD - Memorial Sloan Kettering Cancer Center, New York

03:00pm - 04:00pm ET

Surrogacy of Progression Free Survival to Overall Survival in Metastasis-Directed Therapies for Oligometastatic Cancer

Speaker: David Chen, MD - University of British Columbia, Vancouver

03:00pm - 04:00pm ET

Patient Reported Outcomes in Oropharyngeal Cancer Treated with Cisplatin vs. Carboplatin+Paclitaxel in Combination with Definitive Intensity-Modulated Proton Therapy

Speaker: Matthew Case, MD - Emory University, Atlanta

03:00pm - 04:00pm ET

Investigating the Association of Metabolic and Cardiovascular Medications with Volume Reduction after Complete Decongestive Therapy in Breast Cancer-Related Lymphedema

Speaker: Nicholas Lum, BHSc - University of Toronto, Toronto

03:00pm - 04:00pm ET

Anatomical Reserve and Neurovascular Coupling in Gynecologic Cancer Survivorship: A Two-Part Hurdle Analysis of Patient-Reported Sexual Function

Speaker: Cheng-Hsueh Kuo, MD - National Taiwan University Hospital, Taipei

03:00pm - 04:00pm ET

Longitudinal Changes in Health-Related Quality of Life and Hope in Radiation Oncology Patients

Speaker: Katherine Jin, BA - Stanford University, Palo Alto

03:00pm - 04:00pm ET

The Acceptability and Appropriateness of Routine ePRO Assessment among Patients with Metastatic Cancer in Radiation Oncology

Speaker: Ethan Steele, MD, MS - University of North Carolina at Chapel Hill, Chapel Hill

03:00pm - 04:00pm ET

Sex-Based Disparities in Long-term Survival after Surgery for Stage I-III Hormone Receptor-Positive Breast Cancer

Speaker: Mei Liu, MD - Cancer Center, Shandong University, Jinan

03:00pm - 04:00pm ET

Evaluating the Relationship between Breast Adiposity and Breast Cancer-Related Lymphedema

Speaker: Nicole Wisener, MSc, BMSc - University of Ottawa, Ottawa

03:00pm - 04:00pm ET

Design and Implementation of Survivorship Care Plans for Adolescents and Young Adults Diagnosed with Thyroid Malignancies

Speaker: Christine Hill-Kayser, MD - University of Pennsylvania, Philadelphia

03:00pm - 04:00pm ET

3D Imaging Analysis of Changes in Vaginal Dimensions After Pelvic Radiotherapy

Speaker: Nicole Munoz, BS - Icahn School of Medicine at Mount Sinai, New York

03:00pm - 04:00pm ET

How Do Oncologists Globally Define Oligometastatic Disease? A Cross-Sectional Survey Study

Speaker: Asra Saeed, MBBS - Dr. Ziauddin Hospital, Karachi

03:00pm - 04:00pm ET

Phase Ib Trial of Cardiac Rehabilitation for Patients Receiving Thoracic Radiation Therapy

Speaker: Kevin Chen, MD, MSCI - Washington University in St. Louis, St. Louis

03:00pm - 04:00pm ET

Skin-Related Quality of Life during Radiotherapy across Diverse Fitzpatrick Skin Types and its Association with Radiation Dermatitis

Speaker: Aya Salem, MD - MD Anderson Cancer Center, Houston

03:00pm - 04:00pm ET

Predictors of Sexual Function Decline Following Combined External Beam Radiation and Brachytherapy for Prostate Cancer

Speaker: Ryan Lee, - Urology of Greater Atlanta, Stockbridge

03:00pm - 04:00pm ET

Patient Experience as Clinical Trial Participants in Radiation Oncology: A Single Institution Survey-Based Study

Speaker: Hyo Jin Ryu, DO - University of California, San Francisco, San Francisco

03:00pm - 04:00pm ET

Non-Surgical Management of Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC) A Real-World 20-Year Cohort Study

Speaker: Cristina Ou, RT, BS - Midwestern University, AZCOM, Glendale

03:00pm - 04:00pm ET

Factors Associated with Hematuria Resolution and Post Treatment Hematuria Related Admissions in Patients with Chronic Radiation Cystitis Treated with Hyperbaric Oxygen Therapy

Speaker: Rachel Moses, MD - Dartmouth Health, Lebanon

03:00pm - 04:00pm ET

Phase II Clinical Trial in Progress: Improving Outcomes in Breast Cancer Patients

Speaker: Madhav Patel, MD, BS - Columbia Presbyterian Medical Center, New York

03:00pm - 04:00pm ET

Applying Virtual Reality in Patient Education at a Proton Center to Improve Treatment Precision and Patient Experience: A Randomized Controlled Trial Protocol

Speaker: Shi-yu Gao, MD - China Medical University Hospital, Taichung

03:00pm - 04:00pm ET

Patient Reported Outcomes for Gynecologic Radiation Oncology (PRO-GRO)

Speaker: Victoria Xu, BS - University of North Carolina at Chapel Hill, Chapel Hill

03:00pm - 04:00pm ET

How Patients Spend Their Time: Time Toxicity in Esophageal Cancer

Speaker: Drishti Panse, MD, BS - Icahn School of Medicine at Mount Sinai, New York

03:00pm - 04:00pm ET

Clinical Predictors of Post-Treatment Quality of Life Following Chemoradiation for Gastrointestinal Malignancies

Speaker: Nikita Gupta, BS - Georgetown University School of Medicine, Washington

03:00pm - 04:00pm ET

Safety and Feasibility of Hypofractionated Radiation Therapy for Relapsed/Refractory Lymphoma: Extended Follow-Up of a Phase I Trial

Speaker: Farris Jaamour, MD, MPH - University of Chicago Medicine, Chicago

03:00pm - 04:00pm ET

Low-Dose Hypofractionated Bridging Radiation (4Gy x 2 Fractions) Prior to CAR T-Cell Therapy for Relapsed/Refractory DLBCL

Speaker: Jonathan Baron, MD - University of Pennsylvania, Philadelphia

03:00pm - 04:00pm ET

Impact of Daily Probiotic Yogurt on Esophageal Dose Parameters and Radiation Esophagitis Incidence in Breast Cancer Radiotherapy

Speaker: Li Bo, - Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University. Xi’an, China, Xi'an

03:00pm - 04:00pm ET

Investigating PET/CT Radiomics for subtype Characterization and Treatment Response Prediction in Hodgkin Lymphoma

Speaker: Andrew Heider, BS - Stanford University, San Jose

03:00pm - 04:00pm ET

Response-Directed Radiotherapy after Methotrexate-Based Systemic Therapy for Patients with Primary CNS Lymphoma

Speaker: Ansel Nalin, MD, PhD - MD Anderson Cancer Center, Houston

03:00pm - 04:00pm ET

Immune Checkpoint Inhibitor Combined with Radiotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma: A Transplant-Free Retrospective Study

Speaker: Yue Liu, MD - National Cancer Center CAMS & PUMC, Beijing

03:00pm - 04:00pm ET

Safety of Concurrent Systemic Therapy and Palliative Radiation in Multiple Myeloma

Speaker: Shannon Jiang, MD - Washington University/B-JH/SLCH Consortium, St. Louis

03:00pm - 04:00pm ET

Clinical Outcomes of Whole Brain Radiotherapy for Methotrexate-Refractory Primary CNS Lymphoma

Speaker: Shayla Murray, BS - Memorial Sloan Kettering Cancer Center, Middletown Township

03:00pm - 04:00pm ET

Safe Integration of Radiation Therapy with Bispecific Antibodies in Relapsed/Refractory B-Cell Lymphomas

Speaker: Jonathan Baron, MD - University of Pennsylvania, Philadelphia

03:00pm - 04:00pm ET

Phase II Study of Low Dose Bridging Radiotherapy prior to Axicabtagene-Ciloleucel in Patients with Relapsed/Refractory Follicular Lymphoma

Speaker: Susan Wu, MD - MD Anderson Cancer Center, Houston

03:00pm - 04:00pm ET

Crizotinib Induction Followed by CHOP-Based Chemotherapy and Consolidative ISRT in a "Sandwich" Strategy for Bulky ALK-Positive Anaplastic Large Cell Lymphoma

Speaker: Tao Liu, MD - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan

03:00pm - 04:00pm ET

Marriage-Related Stigma in Young Female Cancer Survivors in India

Speaker: Harshil Sai Vangipuram, MBBS - All India Institute of Medical Sciences, New Delhi

03:00pm - 04:00pm ET

Long-Term Survival and Associated Idiopathic Pneumonia Syndrome (IPS) Outcomes Following Total Body Irradiation (TBI)-Conditioned Hematopoietic Stem Cell Transplantation (HSCT) for Acute Leukemia

Speaker: Syed Shah, MD - University of Minnesota, Minneapolis

03:00pm - 04:00pm ET

Outcomes of Focal Radiation Therapy in the Treatment of Primary and Secondary Central Nervous System Lymphoma

Speaker: Ellen Ruan, BS - Midwestern University, AZCOM, Glendale

03:00pm - 04:00pm ET

Comprehensive Bridging Radiation to All Sites of FDG-Avid Disease Prior to CAR T-Cell Infusion in Patients with Large B-Cell Lymphoma: A Prospective Trial

Speaker: Colton Ladbury, MD - City of Hope National Medical Center, Duarte

03:00pm - 04:00pm ET

Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for Relapsed/Refractory Non-Hodgkin Lymphoma

Speaker: Shubei Wang, MD - Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai

03:00pm - 04:00pm ET

Cardiopulmonary Outcomes in Pediatric and Adult Lymphoma Patients Treated with Modern Radiation Techniques

Speaker: Insia Kizilbash, BS - Mayo Clinic, Scottsdale

03:00pm - 04:00pm ET

Do PET-Avidity Changes after Definitive Radiation Therapy for Solitary Bone Plasmacytoma Predict Progression to Multiple Myeloma?

Speaker: Shane Neibart, MD, MS - Harvard Radiation Oncology Program, Boston

03:00pm - 04:00pm ET

Comparative Outcomes of Radiation Therapy in Mycosis Fungoides and Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoproliferative Disorder

Speaker: Ashish Nalla, BS - Case Western Reserve University School of Medicine, Cleveland

03:00pm - 04:00pm ET

Beyond Acute Toxicity: Persistent and Increasing Body Image Distress after Adjuvant Breast Radiotherapy

Speaker: Sarah Armenia, MD, MS - Cedars-Sinai Medical Center, Los Angeles

03:00pm - 04:00pm ET

A Phase I/II Study of Intralesional IL-2, Hypofractionated Radiotherapy, and Pembrolizumab In Patients Refractory to Standard-of-Care PD-1/PD-L1 Checkpoint Blockade

Speaker: Ajay Fernandez, DO - UC Davis Comprehensive Cancer Center, Sacramento

03:00pm - 04:00pm ET

Moderate Hypofractionated Radiation Therapy for Rosai-Dorfman Disease

Speaker: Xavier Rodriguez-Lopez, MD, BS - Duke University Hospital, Durham

03:00pm - 04:00pm ET

Characterizing Pulmonary Toxicity After Low Dose-Rate AP/PA Total Body Irradiation: A Single-Center Experience

Speaker: Erica Shen, MD, PhD, MBA - Yale Medicine, New Haven

03:00pm - 04:00pm ET

Effect of Dose Escalation of Radiotherapy in Relapse/Refractory Non-Hodgkin's Lymphoma Patients

Speaker: Eileen Samuel, MD - Roswell Park Cancer Institute, Buffalo

03:00pm - 04:00pm ET

Inpatient Radiation Oncology Consultations for Hematologic Malignancies: Indications, Management Patterns, and Outcomes

Speaker: Alok Deshane, MD - MSKCC, New York

03:00pm - 04:00pm ET

Spatial and Dosimetric Benefits of FBCT-Based Online Adaptive Radiotherapy for Gastric MALT Lymphoma

Speaker: Xiumei Ma, MD - Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

03:00pm - 04:00pm ET

Risk-Adapted Consolidative Radiotherapy in Rituximab-Treated Diffuse Large B-Cell Lymphoma: A Single-Institution Cohort

Speaker: Tao Liu, MD - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, Wuhan

03:00pm - 04:00pm ET

Use of 3D-Printed Bolus and Immobilization Devices in Testicular Lymphoma Radiotherapy: A Retrospective Dosimetric and Technical Feasibility Study

Speaker: Vikas Pandey, MD, MBBS - University of Manitoba/Cancer Care Manitoba, Winnipeg

03:00pm - 04:00pm ET

Factors Affecting Quality of Life in Breast Cancer Patients: An Analysis of a Prospective Clinical Trial Using FACT-B Questionnaire Scores

Speaker: Nadine Tayeb, MD, BS - Corewell Health William Beaumont University Hospital, Royal Oak

03:00pm - 04:00pm ET

Prophylactic Levothyroxine for Patients Receiving Radiotherapy for Mediastinal and Neck Lymphomas

Speaker: Kelsey Frechette, MD - Mayo Clinic College of Medicine and Science Rochester, Rochester

03:00pm - 04:00pm ET

Development and Validation of an Automated Workflow for Re-Irradiation Constraint Generation In Radiation Therapy

Speaker: Beatriz Guevara, MS - University Hospitals Cleveland Medical Center, Cleveland

03:00pm - 04:00pm ET

Stereotactic MR-Guided Adaptive Radiotherapy (SMART) for Liver Metastases

Speaker: Neris Dincer, MD - Acibadem Universitesi, Istanbul

03:00pm - 04:00pm ET

Performance of an AI Language Model in Identifying Patients with High-Risk Asymptomatic Bone Metastases on PET/CT Imaging

Speaker: Robert Walker, MD, MS - Thomas Jefferson University, Philadelphia

03:00pm - 04:00pm ET

Cumulative EQD 2 Dose Reporting from an Adaptive Reirradiation Phase I Trial of Ablative 5-Fraction Stereotactic MR-Guided Radiotherapy for Abdominal and Pelvic Tumors

Speaker: Kathryn Mittauer, PhD - Miami Cancer Institute- Baptist Health South Florida, Miami

03:00pm - 04:00pm ET

Pain Outcomes and Survival after Radiotherapy for Malignant Psoas Syndrome: A Multicenter Cohort

Speaker: Yojiro Ishikawa, PhD - Tohoku Medical and Pharmaceutical University, Sendai

03:00pm - 04:00pm ET

Hemostatic Palliative Radiotherapy for Bleeding Upper Gastrointestinal Tumors: A Retrospective Study

Speaker: Kenta Nimura, MD - Aichi Cancer Center Hospital, Nagoya

03:00pm - 04:00pm ET

Glasgow Prognostic Score as a Strong Predictor of Early Mortality in Real-World Palliative Radiation Therapy for Stage IV Lung Cancer

Speaker: Hidekazu Tanaka, MD, PhD - Yamaguchi University Graduate School of Medicine, Ube

03:00pm - 04:00pm ET

Association of CT-Detected Proximal Airway Obstruction with Clinical Airway Events and Survival in Patients Receiving Palliative Thoracic Radiotherapy

Speaker: Hannah Bacon, MD, PhD - University of Toronto, Toronto

03:00pm - 04:00pm ET

Prospective Evaluation of Acute Cutaneous Toxicity during Proton vs. Photon Radiotherapy for Patients with Head and Neck Cancer and Varied Baseline Skin Pigmentation

Speaker: Rehema Thomas, MD - MD Anderson Cancer Center, Houston

03:00pm - 04:00pm ET

Deformable Image Registration Validation for Re-Irradiation: A Landmark-Based Assessment across Diverse Disease Sites

Speaker: Shupeng Chen, PhD - Emory University School of Medicine, Atlanta

03:00pm - 04:00pm ET

Assessment of Palliative Radiotherapy Quality in a Rural Prefecture of Japan: A Multi-Institution Study

Speaker: Yuki Wada, MD, PhD - Akita University Hospotail, Akita

03:00pm - 04:00pm ET

Clinical Efficacy and Dosimetric Comparison of Hybrid Lattice Radiotherapy Using CyberKnife and Conventional Linac for Bulky Tumors

Speaker: Suqing Tian, MD, PhD - Peking University Third Hospital, Beijing

03:00pm - 04:00pm ET

PET Imaging for Modeling of Skeletal Related Events (SREs) in Patients with Asymptomatic High-Risk Bone Metastases

Speaker: Pete Yeh, MD - University of Washington School of Medicine, Seattle

03:00pm - 04:00pm ET

Clinical Outcomes of Inpatient Palliative Radiotherapy for Malignant Airway Obstruction: A Retrospective Cohort Study

Speaker: Bryn Myers, MD - Cleveland Clinic Foundation, Cleveland

03:00pm - 04:00pm ET

Radiation Therapy for Oligometastatic Lymph Node Progression in Hepatocellular Carcinoma: Survival and Failure Outcomes

Speaker: Anna Skakodub, MD - Mount Sinai, New York

03:00pm - 04:00pm ET

Dose-Response Relationship across Radiotherapy Modalities In Recurrent and Metastatic Ovarian Cancer: A Retrospective Analysis

Speaker: Lifei Zhu, MD, PhD - Montefiore Medical Center/Albert Einstein College of Medicine, Bronx

03:00pm - 04:00pm ET

Post-Hoc Subgroup Analysis of Patients with Breast Cancer Experiencing Polymetastatic Progression on CURB Oligoprogression Trial

Speaker: Shoshana Rosenzweig, MD - Memorial Sloan Kettering Cancer Center, New York

03:00pm - 04:00pm ET

Dosimetric Predictors and Clinical Risk Factors for Radiation Pneumonitis In Lung Cancer Patients Receiving Intensity-Modulated Proton Re-Irradiation: A Retrospective Cohort Study

Speaker: Yingfan Guo, - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan

03:00pm - 04:00pm ET

Does Intensity Modulated Proton Therapy Reduce Clinical Hypothyroidism after Supraclavicular Irradiation for Breast Cancer?

Speaker: Nikolai Strusberg, MD - Baptist Health Herbert Wertheim Cancer Institute, Miami

03:00pm - 04:00pm ET

Modern Outcomes after Multimodality Therapy without Supraclavicular Dissection in N3c Breast Cancer

Speaker: Xuwen Shen, MD - cancer hospital of Chinese academy of Sciences, Beijing

03:00pm - 04:00pm ET

Factors Associated with Non-Completion of Palliative Radiation Therapy in Patients with Metastatic Cancer

Speaker: C Jillian Tsai, MD, PhD, MS - Princess Margaret Cancer Centre, Toronto

03:00pm - 04:00pm ET

Clinical Implementation of a Low-Dose Hyper-Radiosensitivity Priming Strategy In Re-Irradiation for Recurrent or Second Primary Head and Neck Cancer: Early Feasibility Experience

Speaker: Yu-Wei Lin, MD, PhD, MS - Kaohsiung Veterans General Hospital, Kaohsiung

03:00pm - 04:00pm ET

Practice Patterns and Perceived Outcomes of Neoadjuvant Systemic Therapy in Head and Neck Cancer : Insights from a Multi-Institutional Indian Survey

Speaker: Amitabh Ray, MD, MBBS, DNB - Chittaranjan National Cancer Institute, Kolkata

03:00pm - 04:00pm ET

Early Prediction of Moderate-to-Severe Radiation-Induced Breast Damage using Ultrasound and Attention-Guided Deep Learning

Speaker: Tian Liu, PhD - Icahn School of Medicine at Mount Sinai, New York

03:00pm - 04:00pm ET

Real-World Feasibility and Dosimetric Bottlenecks of the FAST-FORWARD Protocol in Right-Sided Whole Breast Radiotherapy

Speaker: Aman Gupta, MD, MBBS - Rajiv Gandhi Cancer Institute and Reserach Centre, New Delhi

03:00pm - 04:00pm ET

Early Patient-Reported Quality of Life after Moderately Hypofractionated vs. Conventional Definitive Radiotherapy for Non-Metastatic Prostate Cancer: A Real-World Study from a Regional Center in China

Speaker: Senxiang Yan, MD, PhD - The 1st Affiliated Hospital College of Medicine Zhejiang University, Hangzhou

03:00pm - 04:00pm ET

Phase I HyDEF Trial: Hypofractionated and Dual Equivalent Fractionated Bridging Radiation Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Undergoing T-Cell Redirection Therapy

Speaker: James Ninia, MD, MS - Yale Therapeutic Radiology, New Haven

03:00pm - 04:00pm ET

The Value of Deep Inspiratory Breath Hold (DIBH) in Right Sided Breast Cancer Radiotherapy

Speaker: Racha Khodor, MD - American University of Beirut Medical Center, Beirut

03:00pm - 04:00pm ET

Identification of Biomarkers for Post-Treatment Cardiotoxicity in Mediastinal Lymphoma Patients

Speaker: Raffaele Barbara, MD, RT - Ospedale Brotzu, Cagliari

03:00pm - 04:00pm ET

Comparison of ASTRO APBI Guidelines (2009, 2017, 2024) for Risk Stratification of Ipsilateral Breast Tumor Recurrence in HDR Brachytherapy-Treated Patients

Speaker: John Wilson V, BS - University of South Florida, Tampa

03:00pm - 04:00pm ET

Matching Clinical Contouring Performance: A Blinded-Rater Study of a Novel Transformer-Based AI Model (TUM-SAM) for Hepatocellular Carcinoma (HCC) Contouring in Mongolia

Speaker: Baozhou Sun, PhD, MBA - Baylor College of Medicine, Houston

03:00pm - 04:00pm ET

Very Accelerated Partial Breast Irradiation (vAPBI) Delivered in Four Fractions: Prospective Feasibility Study Using Multi-Catheter Interstitial Brachytherapy in India

Speaker: Surendra Saini, MD, PhD, DPH, FESTRO - All India Institute of Medical Sciences, New Delhi

03:00pm - 04:00pm ET

A Comparative Study of Proton vs. Photon Volumetric Modulated Arc Therapy Craniospinal Irradiation for Hematologic Leptomeningeal Disease

Speaker: Gene Lamanilao, MD - University of California San Diego, La Jolla

03:00pm - 04:00pm ET

Pattern Practice for Cognitive Preservation Strategies in Patients Receiving Whole-Brain Radiation Therapy: A Study from Middle Eastern Countries

Speaker: Renda Alhabib, MD - King Fahad Specialist Hospital, Dammam

03:00pm - 04:00pm ET

The Role of Tumor-Intrinsic Interferon Signaling and Associated Microenvironmental Remodeling in Solid Tumor CAR T-Cell Therapy Response

Speaker: Sharareh Gholamin, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte

03:00pm - 04:00pm ET

Minibeam Radiation Therapy Combined with Bevacizumab and the Tumor Immune Microenvironment

Speaker: Jinyi Lang, MD, PhD - Sichuan Cancer Hosiptal and Institute, Chengdu

03:00pm - 04:00pm ET

A Prospective Observational Cohort Study Of Hypofractionated Palliative Radiotherapy (10 Gy x 3) For Advanced Cervical Cancer In Sub-Saharan Africa

Speaker: Kgosi Hughes, BS - University of Oklahoma Health Sciences Center, Oklahoma City

03:00pm - 04:00pm ET

Effect of Timing of Total Skin Electron Therapy on Clinical Outcomes in Patients with Mycosis Fungoides

Speaker: Payton Dolan, BS, BSBME - Henry Ford Health, Jackson

03:00pm - 04:00pm ET

Maintaining Radiotherapy Capacity during War: A Nation-Wide Study from Ukraine

Speaker: Nataliya Kovalchuk, PhD - Stanford University School of Medicine, Palo Alto

03:00pm - 04:00pm ET

Skin Dose Assessment in Prone Accelerated Partial Breast Irradiation Using a Personalized 3D-Printed Immobilization Device

Speaker: Daniel Zwahlen, MD, MBA - Department of Radiation Oncology, Winterthur

03:00pm - 04:00pm ET

Comparison of Ultrahypofractionated Radiotherapy In Breast Cancer to Longer Schedules: A Meta-Analysis of Randomized Trials

Speaker: Juliane Hoerner-Rieber, MD - University Hospital Duesseldorf, Düsseldorf

03:00pm - 04:00pm ET

A Novel "Lying-on-Couch" Total Skin Electron Beam Therapy (TSEBT) to Improve Access, Reproducibility, and Ergonomics for Frail and Non-Ambulatory Patients

Speaker: Bin Han, PhD - Stanford University, Palo Alto

AMA PRA Category 1 Credits:	0.00
CAMPEP Credits:	0.00
MDCB Credits:	0.00

PQA 04 - Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Functional Radiation Medicine, Hematologic Malignancies, Palliative Care, and International/Global Oncology

session DESCRIPTION

Credits

Rate This Session

Presentations

Outcomes of Curative-Intent Cancer Therapy in a Decentralized Regional Cancer Center In India

Radiotherapy Demand and Available Resources in Central America

Nursing in Radiation Oncology: Effectiveness of a Remote International Curriculum

From Electives to Enduring Partnerships: A Scalable Checklist-Based Framework for Global Radiation Oncology Training

Pilot Chart Rounds Workshop for Radiation Oncology Residents in the Philippines

Global Radiotherapy Demand in Cervical Cancer: A Scoping Review of Optimal Utilization Modeling

Beyond Patient Outcomes: Radiation Oncology (RO) and Public Health Researcher (PHR) Collaboration Assessing Caregiver Quality of Life (QOL) during Long Course Radiotherapy

Strengthening Radiation Oncology in Ukraine through Coordinated Education and Global Partnership

Quantifying Radiation Therapy Needs in a Prospective Cohort of Lymphoma Patients in Malawi

Barriers to Implementing Neoadjuvant Therapy In Clinical Trials: Insights from a Low- to Middle- Income Country

Career Pathways in Global Radiation Oncology: Training Gaps, JobMarket Realities, and Workforce Implications

Neurological Complication of Stereotactic Ablative Radiotherapy for Spinal Metastases

Prospective Multi-Institutional Outcomes Using a 1.5 Tesla MR Linac in the Treatment of Adrenal Metastatic Lesions with Stereotactic Ablative Body Radiation (SABR), A Report from the MOMENTUM Study

The Inpatient Metastatic Spine Score: Prospective Validation on a Phase Two Randomized Controlled Trial

Characterization of Cannabis Use In Patients with Prostate, Lung, and Breast Cancer Enrolled in a Statewide Multicenter Cohort

Total RadIoTherapy of Oligometastatic caNcerS (TRITONS): A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for =10 Metastatic Sites in Patients Receiving Systemic Therapy

Impact of Tumor Volume on Dosimetry and Sphere Conformality in Lattice Radiation Therapy

Palliative EBRT among Patients Receiving Lu-PSMA-617 for Polymetastatic Prostate Cancer: Local Control and Survival Outcomes

Beyond Conventional Palliation: Outcomes of Spatially Fractionated Radiation Therapy (SFRT) In the Era of Prolonged Metastatic Survival

Polymetastatic Lesion Ablative Radiotherapy with Immunotherapy Study (POLARIS): A ctDNA-Guided Phase II Trial for Patients with Metastatic Advanced Solid Tumors

Lymphocyte Kinetics and Outcomes After Comprehensive Involved-Site Radiotherapy for Oligometastases

Palliative Spatially Fractionated Radiotherapy (SFRT): Institutional Experience Evaluating Subjective Treatment Response and Metabolic Safety

An Analysis of Acute-on-Chronic Pain and Opioid Dependency In a Prospective Head and Neck Cancer Cohort Treated with Radiation Therapy

Temporal Trends in Stereotactic Body Radiation Therapy (SBRT) Utilization for Extracranial Metastatic Disease

Outcomes in Hospitalized Patients Evaluated for Palliative Radiation Therapy for Tumor-Related Bleeding

Repeat Irradiation for In-Breast Tumor Recurrence Following Breast Conservation for Early Stage Breast Cancer

Clinical Predictors of 1-Year Mortality After Stereotactic Body Radiotherapy (SBRT) for Metastatic Cancer

Investigation of Clinical Availability of the Halcyon CBCTp Workflow for Palliative Radiotherapy

The 5-Year Follow-Up Results of the Efficacy and Safety of Pulse Low-Dose-Rate Radiotherapy (PLDR) Re-Irradiation in Recurrent Nasopharyngeal Carcinoma Patients, A Prospective, Open-Label,Multicenter, Phase II Clinical Trial

Patient Experiences with a Pilot Exercise Coaching Intervention during Pelvic Radiation: Interim Qualitative Analysis

Toxicity Outcomes Following Spine Stereotactic Body Radiotherapy and Bevacizumab

Real-World Efficiency and Pain Outcomes of VMAT for Palliative Radiotherapy of Bone Metastases

Comparison of Patient-Reported Side Effects Between Leuprolide and Relugolix in Prostate Cancer Patients Receiving Radiation Therapy

Palliative Radiotherapy for Metastases to the Calvarium and Skull Base: A Systematic Review and Pooled Analysis

An Institutional Experience of Radiotherapy for Sialorrhea in Patients with Amyotrophic Lateral Sclerosis

Adjuvant Post-Operative Interstitial Brachytherapy Versus Superficial X-Ray for Pediatric Keloids: Which to Choose?

Quantification of Error Sources in Stereotactic Arrhythmia Radioablation Treatment Planning and Delivery

Beyond BNI: Development and Validation of a Domain-Based Neuromodulation Score for Trigeminal Neuralgia Radiosurgery

Low-Dose Radiotherapy for Refractory Post-Traumatic Chronic Osteomyelitis: A Retrospective Case Series

Low-Dose Electron Beam Radiotherapy in the Treatment of Peyronie's Disease: Evaluation of Tolerance and Efficacy

Long-Term Skin-Related Quality of Life in Patients Receiving Post-Operative Radiation Therapy for Cutaneous Melanoma

Automated Radiation Treatment Planning for Low-Dose Radiotherapy in Knee Osteoarthritis

Evaluation of Respiratory and Cardiac Motion Effects in Proton Therapy for Ventricular Tachycardia

First-in-Human Craniospinal Low-Dose Radiation Therapy for Progressive Multiple Sclerosis: A Case Report

Incidence and Dosimetric Correlates of Adverse Events in Stereotactic Arrhythmia Radioablation: A Prospective Registry Analysis

DTI-Based Trigeminal Response Index Predicts 5-Year Radiosurgery Durability

Predictors of Heterotopic Ossification after Acetabular Fixation: Secondary Analysis of a Randomized Trial of Prophylactic Radiation

Ring Gantry Linear Accelerator Based Total Lymphoid Irradiation (TLI) Based Myeloablative Conditioning Regimen in Hematopoietic Stem Cell Transplant (HSCT) in Thalassemia: A Single Institute Experience

Mechanism-Based Recurrence Phenotyping after Trigeminal Radiosurgery

Vascular Phenotype-Guided Radiosurgery for Trigeminal Neuralgia with Vertebrobasilar Dolichoectasia

Low-Dose Radiation Therapy for Facetogenic Back Pain and Spondyloarthropathy: Early Results from a Prospective Cohort

American Heart Association Cardiovascular Health Metrics and Cancer Outcomes: A Systematic Review and Meta-Analysis

CT Simulation Free Workflow for Low Dose Radiotherapy for Osteoarthritis

Image Guided IMRT for Thyroid Eye Disease: A Single-Center Study Using a Uniform 18 Gy Regimen

Early Ventricular Tachycardia Suppression after Cardiac Radioablation using SABR Suggests Electrical Conduction Remodeling Rather Than Fibrosis: Clinical Timeline Outcomes and Dosimetric Correlates

Phase II Randomized Trial of Low-Dose Radiation Therapy plus Donanemab in Early Alzheimer's Disease: A Radiation-as-a-Drug Approach (RAD-CLEAR)

Long-Term Complete Obliteration Rates after LINAC-Based Stereotactic Radiosurgery for Arteriovenous Malformations: A Retrospective Analysis

Clinical Evaluation of Joint Respiratory and Cardiac Phase Binning 4DCT Based on mmWave Signals

Spatially Fractionated Radiosurgery for Large AVMs: An Early Experience of Dosimetry and Patient Outcomes

Efficacy and Safety of Metastasis-Directed Therapy for Oligometastatic Cancer

OSTEO: A Framework for Evaluating Low-Dose Radiotherapy Plans for Osteoarthritis

Outcomes of High-Dose Gamma Knife Radiosurgery for Medically Refractory Trigeminal Neuralgia: A Single-Institution Experience

LD-EBRT for Coxarthrosis and GTPS: Correlations between the Season, the Irradiation Area, and the Initial Increase in Pain

Comparative Outcomes of CyberKnife Stereotactic Radiosurgery for Idiopathic and Multiple Sclerosis-Related Trigeminal Neuralgia: A Single-Institution Study

Radiobiological Mechanism and Quantification of Low-Dose Radiation Therapy (LDRT) for Osteoarthritis Pains

Patient-Reported Outcomes Following Radiotherapy for Extremity Fibromatosis: A Single Institution Retrospective Cohort Review

A Prospective Evaluation of the Efficacy of Intravascular Brachytherapy

Temporal Dose Structuring Guided by Ion-Channel Recovery Dynamics in Trigeminal Neuralgia Radiosurgery

Outcomes of Adjuvant Radiotherapy for Pigmented Villonodular Synovitis: A Single-Institution Experience

Impact of a Digital Education Platform on Patient Understanding of Prostate Cancer Treatment Options and Provider Communication: A Prospective Multi-Provider Pilot Study

LINAC-Based Fractionated Stereotactic Radiosurgery (fSRS) for Cervical Spine Arteriovenous Malformation (AVM): A Case-Based Treatment Planning Framework

Functional and Dosimetric Outcomes of IMRT in the Management of Graves Eye Disease

Low-Dose Radiation Therapy for Spinal Osteoarthritis: A Retrospective Review of Pain Outcomes

Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II) Prospective Clinical Trial

PROTECT-CPAP: A Prospective Study of Cardiac and Pulmonary Dose Reduction Using Continuous Positive Airway Pressure in Left-Sided Breast Radiotherapy